7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		               
      cash flows from operating activities
    		               
      net income
    		4,509,000 -266,000 5,127,000 12,854,000 11,051,000 1,314,000 4,744,000 7,382,000 7,534,000 5,163,000 -10,108,000 -13,179,000 -30,609,000 -20,771,000 -39,675,000 
      adjustments to reconcile net income to net cash from operating activities:
    		               
      depreciation and amortization
    		11,373,000 11,339,000 10,406,000 9,636,000 9,195,000 8,426,000 7,670,000 7,322,000 6,655,000 5,558,000 5,254,000 5,539,000 5,394,000 5,082,000 3,775,000 
      amortization of right-of-use assets
    		887,000 866,000 618,000 284,000 479,000 682,000 687,000 681,000 675,000 759,000      
      amortization of debt issuance costs
    		49,000 56,000 56,000 57,000 57,000 56,000 57,000 57,000 58,000 57,000 58,000 56,000 56,000 57,000 62,000 
      stock-based compensation
    		28,369,000 30,638,000 29,756,000 22,024,000 15,715,000 18,915,000 14,856,000 15,010,000 15,582,000 15,979,000 19,778,000 22,847,000 21,865,000 25,871,000 38,141,000 
      deferred income taxes
    		11,229,000 -7,721,000 1,996,000 -3,811,000 138,000 -2,142,000 1,263,000 -6,106,000 3,204,000 -959,000 -1,789,000 -836,000 2,791,000 -4,377,000 -5,606,000 
      change in fair value of other equity security
    		0 0 -302,000           -781,000  
      unrealized foreign exchange gain
    		           2,026,000 1,379,000   
      gain on sale of assets held for sale
    		0 0 -14,337,000             
      gain on sale of available-for-sale debt security
    		0               
      loss on disposal of property and equipment
    		53,000 -2,000 99,000             
      other
    		       0 -38,000 169,000 0   0 0 
      changes in operating assets and liabilities:
    		               
      accounts receivable
    		2,595,000 -5,106,000 -9,148,000 3,007,000 3,656,000 553,000 -3,989,000 2,387,000 -630,000 397,000 -545,000 -207,000 -2,150,000 1,529,000 -732,000 
      prepaid expenses and other current assets
    		-4,623,000 5,964,000 -2,238,000 2,546,000 1,944,000 -4,507,000 -2,758,000 2,342,000 -4,192,000 37,000 -143,000 6,289,000 -6,706,000 597,000 -3,869,000 
      other assets
    		920,000 -121,000 204,000 649,000 312,000 -298,000 44,000 90,000 341,000 1,043,000 -519,000 466,000 -811,000 -1,365,000 -1,615,000 
      accounts payable
    		-2,531,000 -875,000 5,329,000 2,919,000 -5,671,000 507,000 1,428,000 -967,000 -2,327,000 -192,000 7,136,000 -13,436,000 -117,000 -12,275,000 6,744,000 
      accrued expenses and other liabilities
    		2,122,000 2,550,000 -3,247,000 2,019,000 134,000 2,777,000 -9,086,000 5,111,000 3,090,000 -1,071,000 -550,000 2,481,000 5,675,000 6,365,000 4,221,000 
      operating lease liabilities
    		-735,000 -520,000 -536,000 -288,000 -458,000 -590,000 -606,000 -596,000 -591,000 -536,000 43,000 -872,000 -770,000   
      income tax payable
    		7,000 233,000 6,000 8,000 7,000 -4,000 -55,000 -20,000 8,000 6,000 7,000 8,000 7,000 183,000 -92,000 
      deferred revenue
    		-127,000 2,797,000 26,838,000 -11,194,000 -3,380,000 1,565,000 19,593,000 -8,991,000 -2,712,000 -5,029,000 5,408,000 -485,000 17,185,000 -6,112,000 215,000 
      net cash from operating activities
    		54,226,000 39,139,000 50,703,000 42,586,000 31,613,000 27,246,000 34,194,000 22,494,000 27,441,000 21,822,000 27,258,000 11,020,000 13,737,000 -6,004,000 19,460,000 
      capex
    		-7,236,000 -7,530,000 -9,378,000 -6,336,000 -10,302,000 -10,243,000 -6,473,000 -7,344,000 -7,428,000 -6,135,000 -5,807,000 -5,468,000 -4,911,000 -3,050,000 -2,594,000 
      free cash flows
    		46,990,000 31,609,000 41,325,000 36,250,000 21,311,000 17,003,000 27,721,000 15,150,000 20,013,000 15,687,000 21,451,000 5,552,000 8,826,000 -9,054,000 16,866,000 
      cash flows from investing activities
    		               
      acquisition, net of cash acquired
    		0 -345,000 -48,123,000             
      proceeds from sale of assets held for sale
    		0               
      proceeds from sale of available-for-sale debt security
    		0               
      purchase of property and equipment
    		-7,236,000 -7,530,000 -9,378,000 -6,707,000 -9,638,000 -9,874,000 -9,477,000 -8,373,000 -7,993,000 -5,657,000 -6,062,000 -5,468,000 -4,911,000 -3,240,000 -2,496,000 
      net cash from investing activities
    		-7,236,000 -6,368,000 -20,450,000 -6,707,000 -9,638,000 -9,874,000 -9,477,000 -8,373,000 -7,955,000 -11,956,000 -8,594,000 -5,465,000 -4,607,000 -65,890,000 -5,779,000 
      cash flows from financing activities
    		               
      payment of debt issuance costs
    		             0  
      proceeds from issuance of stock under employee stock plans
    		5,000 1,109,000 43,548,000 552,000 220,000 1,560,000 82,000 2,755,000 2,717,000 756,000 195,000 1,250,000 237,000   
      repayment of capital lease obligations
    		0 0 -2,000  -6,000 -7,000 -6,000  -9,000    -4,000 -7,000 -8,000 
      repurchase of common stock
    		-17,202,000    -25,509,000 -123,667,000 -12,783,000  -45,064,000  -22,581,000 -38,061,000 -1,094,000   
      share repurchase costs
    		0               
      shares surrendered for settlement of minimum statutory tax withholding
    		-8,793,000 -5,230,000 -5,942,000 -3,275,000 -3,056,000 -4,596,000 -9,564,000  -3,884,000  -11,000     
      net cash from financing activities
    		-26,831,000 -25,804,000 37,604,000 -5,953,000 -28,351,000 -126,710,000 -22,271,000 -587,000 -46,240,000 -32,648,000 -22,397,000 -37,426,000 -872,000 521,000 130,084,000 
      effect of exchange rate changes on cash and cash equivalents
    		-40,000 95,000 52,000 -339,000 58,000 4,000 -36,000  -36,000  8,000     
      net increase in cash and cash equivalents
    		20,119,000 7,062,000 67,909,000 29,587,000 -6,318,000 -109,334,000 2,410,000  -26,790,000       
      cash and cash equivalents, at beginning of the period
    		0 0 142,064,000 0 0 0 225,719,000  0       
      unrealized foreign exchange loss
    		 -45,000 76,000             
      cash and cash equivalents, at end of the period
    		 7,062,000 209,973,000 29,587,000 -6,318,000 -109,334,000 228,129,000 13,572,000 -26,790,000       
      non-cash operating, investing, and financing activities:
    		               
      acquisition-related deferred consideration
    		 0 13,058,000             
      proceeds from disposal of assets held for sale
    		  37,051,000             
      issuance of common stock for business acquired
    		  20,048,000             
      impairment of long-lived assets
    		         11,000     493,000 
      impairment of other equity security
    		               
      change in fair value of contingent consideration
    		       0 -141,000 0 0     
      changes in operating assets and liabilities, net of effects of business combinations, asset acquisition and disposal of business:
    		               
      acquisitions, net of cash acquired
    		               
      asset acquisition, net of cash acquired
    		               
      proceeds from acquisition working capital adjustment
    		         0 0 3,000 304,000   
      repayment of finance lease obligations
    		               
      payment of contingent consideration
    		         0 0   0 -549,000 
      repurchase and retirement of shares
    		               
      payment of stock repurchase costs
    		               
      supplemental cash flow data
    		               
      cash paid during the year for:
    		               
      income taxes
    		               
      right of use assets obtained in exchange for new operating lease liabilities
    		               
      capitalized stock-based compensation
    		   1,387,000 1,536,000 1,627,000 1,417,000 1,017,000 1,053,000 747,000 549,000     
      purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities
    		   371,000 -664,000 -369,000 3,004,000 1,029,000 565,000 -478,000 255,000   190,000 -98,000 
      accrued stock repurchase excise tax
    		   -48,000 206,000   -107,000        
      unrealized foreign exchange (gain) loss
    		    -1,615,000 -8,000 346,000 -1,208,000 925,000       
      receivable from issuance of stock under employee stock plans
    		               
      accrued stock repurchase costs
    		    -778,000           
      right-of-use assets under operating leases
    		          5,351,000     
      amortization of prior hedge effectiveness
    		             0 19,000 
      loss on debt extinguishment
    		             0  
      discontinuance of interest rate swaps and write-off of prior hedge effectiveness
    		             0  
      change in fair value of financial guarantee
    		             0 0 
      change in fair value of derivative instruments
    		             0 364,000 
      payment upon extinguishment of interest rate swaps
    		             0  
      purchase of other equity security
    		               
      repayment of finance and capital lease obligations
    		               
      repayment of 2018 term loan
    		             0 -521,625,000 
      repayment of hybrid debt
    		             0 0 
      payment upon extinguishment of hybrid debt
    		             0  
      repurchase and retirement of common stock
    		               
      payment of special dividends
    		             3,000 -68,000 
      proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions
    		             0  
      proceeds from private placement, net of underwriting discounts and commissions
    		             0  
      payment of stock issuance costs
    		             -2,000  
      shares surrendered for settlement of minimum statutory tax withholdings
    		               
      effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent
    		            -51,000 -34,000 -33,000 
      net increase in cash, cash equivalents and restricted cash equivalent
    		            8,207,000 -71,407,000 143,732,000 
      cash and cash equivalents and restricted cash equivalent, at beginning of the period
    		               
      interest
    		               
      conversion of series a redeemable convertible preferred stock into common stock in connection with initial public offering
    		             0  
      change in fair value of hedged interest rate swaps and interest rate cap
    		             0 -2,684,000 
      changes in operating assets and liabilities, net of effects of business combination:
    		               
      contingent consideration for acquired business
    		               
      impairment of available for sale debt security
    		               
      loss on sale of business
    		               
      the accompanying notes are an integral part of these consolidated financial statements
    		               
      sale of business, net of cash sold
    		               
      proceeds from 2018 revolving facility
    		               
      repayment of 2018 revolving facility
    		               
      tender offer costs
    		               
      repurchase and retirement of common stock for tax withholding obligations
    		               
      cash, cash equivalents and restricted cash equivalent, at beginning of the period
    		             0 0 
      cash, cash equivalents and restricted cash equivalent, at end of the period
    		             -71,407,000 143,732,000 
      reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets
    		               
      cash and cash equivalents
    		             -71,407,000 143,732,000 
      restricted cash equivalent
    		               
      total cash, cash equivalents, and restricted cash equivalent shown in the consolidated statements of cash flows
    		               
      non-cash investing and financing activities
    		               
      transfer of interest rate swaps derivative liability to hybrid debt
    		               
      contingent consideration for business acquired
    		               
      impairment of other equity securities
    		          0 0 170,000   
      net increase in cash and cash equivalents, and restricted cash equivalents
    		          -3,725,000     
      cash and cash equivalents, and restricted cash equivalents, at beginning of the period
    		          0     
      cash and cash equivalents at end of the period
    		          -3,725,000     
      non-cash investing and financing activities:
    		               
      amortization of right-of-use asset
    		           474,000 378,000   
      payment of initial public offering costs
    		               
      deferred offering costs included in accounts payable and accrued expenses and other current liabilities
    		               
      deferred financing costs included in accounts payable and accrued expenses and other current liabilities
    		               
      deferred offering costs
    		               
      repurchases of common stock for tax withholding obligations
    		            -11,000 -880,000 -1,253,000 
      impairment of goodwill and long-lived assets
    		               
      impairment of available-for-sale debt securities
    		               
      changes in operating assets and liabilities, net of effects of business combinations and disposal of business:
    		               
      purchase of available-for-sale debt securities
    		               
      proceeds from sale of equity method investment
    		               
      repurchase of common stock and restricted stock units
    		               
      payment of deferred purchase consideration
    		               
      conversion of available-for-sale debt security into other equity security
    		               
      changes in operating assets and liabilities, net of effects of disposal of business:
    		               
      proceeds from exercise of stock options, net of cash paid for employee tax withholding
    		              85,000 
      total cash, cash equivalents, and restricted cash equivalent shown in the condensed consolidated statements of cash flows
    		              143,732,000 
      impairment of investments
    		               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.